SNT
VRTX icon

Security National Trust’s Vertex Pharmaceuticals VRTX Stock Holding History

Security National Trust’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-185
Closed -$28K – 403
2017
Q4 		$28K Hold
185
– – 0.01% 290
2017
Q3 		$28K Buy
+185
New +$27.8K 0.01% 293
2016
Q1 		– Sell
-141
Closed -$18K – 486
2015
Q4 		$18K Hold
141
– – 0.01% 334
2015
Q3 		$15K Hold
141
– – 0.01% 348
2015
Q2 		$17K Hold
141
– – 0.01% 354
2015
Q1 		$17K Hold
141
– – 0.01% 362
2014
Q4 		$17K Buy
+141
New +$15.9K 0.01% 364
2014
Q1 		– Sell
-23
Closed -$2K – 543
2013
Q4 		$2K Hold
23
– – ﹤0.01% 507
2013
Q3 		$2K Buy
+23
New +$1.83K ﹤0.01% 493

Other funds holding VRTX

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return